Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
"An apple a day keeps the doctor away." Growing up, this sing-song refrain stood as nothing more than a reminder from my parents to eat my fruits and veggies. But it…
Continue Reading“An Apple a Day:” Fruit Peel Compounds May Reverse Neural Damage from Multiple Sclerosis
According to CNBC, there is a shortage across the country of a very important medication: hydroxychloroquine. This is somewhat unsurprising. After all, the Trump administration has been vocal about the…
Continue ReadingHydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?
According to Business Insider, cases of COVID-19 and deaths attributed to it are rising rapidly. The pandemic was officially declared on March 10th, just about one month ago. At the…
Continue ReadingHow 15 Drugmakers Are Making Headway Against the Coronavirus Pandemic
According to an article in The Asahi Shimbun, Japanese scientists have developed a new vaccine to mitigate neuronal degeneration caused by Alzheimer's disease. The vaccine, delivered nasally, had promising results…
Continue ReadingNasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease
According to Parkinson's News Today, Dutch neurologist Bastiaan Bloem, MD, believes that the development of Parkinson's disease can be attributed to chemical exposure. About Parkinson's Disease Parkinson's disease is…
Continue ReadingChemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist
According to an article in Healio, the immunosuppressing drug voclosporin was found to be effective in stimulating renal responses in patients with lupus nephritis. About Lupus Nephritis Lupus nephritis…
Continue ReadingAURORA Study Finds Voclosporin Effective for Lupus Nephritis Treatment
According to Healio, a recent study has found that patients with ovaries who have asthma or chronic obstructive pulmonary disease (COPD) are at a higher risk of developing rheumatoid…
Continue ReadingRheumatoid Arthritis Risk Greater in Patients with Asthma, COPD
According to Oren Goldshtein, CEO of Vectorious Medical Technologies, remote patient monitoring is needed now more important than ever. Nobody knows how long the COVID-19 pandemic will last or…
Continue ReadingCOVID-19 Reveals the Future Necessity of Remote Patient Monitoring
The Health Medicine Network has shared that researchers found a potential early biomarker that could help track the development of non-alcoholic fatty liver disease. With up to 80% of…
Continue ReadingStudy Finds Biomarker for Non-Alcoholic Fatty Liver Disease
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)
According to new research from the Journal of Infectious Diseases, a new protein epitope has been discovered while testing the immune response of people with Kawasaki Disease. Kawasaki Disease, also…
Continue ReadingNew Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
As originally discussed in Muscular Dystrophy News Today, a recent study has discovered that increasing levels of utrophin in the body can improve muscle strength, form, and function for patients…
Continue ReadingUtrophin for Patients with Duchenne Muscular Dystrophy
How will this affect my child? Will this diagnosis change the way my child can receive medical treatment? If an emergency arises, do I have the knowledge needed to…
Continue ReadingIs It Safe to Anesthetize Young Patients with Batten Disease?
According to a press release from the Mayo Clinic, new research findings show that in-utero neurological surgery for patients with spina bifida is more successful in strengthening brain structure…
Continue ReadingFetal Spina Bifida Surgery Shown to Restore Brain Structure
If you're worried or anxious because of COVID-19, you're not alone. If wondering about the intersection of rare diseases and COVID-19 only increases that anxiety, well, we're with you…
Continue ReadingHandling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
According to a story from Wexford People, 8-year-old Mia-Lily Ruttle wants to spread some hope to people around the globe. The girl, who has neurofibromatosis, was upset by the impact…
Continue ReadingPlanting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety
According to a news release from the American College of Cardiology, rivaroxaban is more effective than enoxaprin (heparin) in preventing blood clots or low platelet counts in patients after…
Continue ReadingRivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin
According to Microbiome Times, Ilya Pharma has received a BIO-X® grant to study gene therapy for patients with inflammatory bowel disease. Their chemokine-based gene therapy drug candidates seek to…
Continue ReadingBIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease
Cuando algunas personas escuchan el "efecto placebo", evoca imágenes de píldoras de azúcar diseñadas para estimular la creencia del paciente. Pero según Healio, el término tiene un significado diferente…
Continue ReadingEl Efecto Placebo y Los Resultados Positivos del Paciente
COVID-19 and its rapid global spread have been anxiety-inducing, to say the least. For patients with rare diseases and their families, the growth of COVID-19 has also prompted additional…
Continue ReadingAutoimmune Hepatitis and COVID-19: Handling Liver Transplants
According to a release on Biospace, the European Commission (EC) has approved Takeda Pharmaceutical's ALUNBRIG (brigatinib) as treatment for patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer…
Continue ReadingALUNBRIG Approved by European Commission as Treatment for Patients with ALK+ NSCLC
If you have read the news at all lately, you know that ventilators are a sought-after piece of medical equipment. With hospitals looking to treat mass amounts of patients…
Continue ReadingHow Do Ventilators Work?: A Video Review During COVID-19
While many patients are grateful for their doctors and treatments, how many know why they are so passionate about what they do? In an interview with Dr. Patrick Flume,…
Continue ReadingHow A Doctor Approaches Care for Patients with Cystic Fibrosis
According to BioSpace, an experimental drug designed to treat cancer and HIV may also be poised to treat patients with COVID-19. The drug, called leronlimab, was created by biotechnology…
Continue ReadingCan Experimental Cancer and HIV Drug Leronlimab Treat COVID-19?
A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…
Continue ReadingEmerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
According to a study summarized in Gastroenterology Consultant, pregnant women with intrahepatic cholestasis of pregnancy are much more likely to also be diagnosed with nonalcoholic fatty liver disease. You can…
Continue ReadingIntrahepatic Cholestasis of Pregnancy and its Link to Non-Alcoholic Fatty Liver Disease
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Sign Up For Our Patient Panel
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.